ArticleJournal of inherited metabolic disease2010

Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy.

John Marshall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.